RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
RT @EricTopol: 97% of #cancer drugs tested fail. Why? When @carlzimmer is on-target about off-target cancer drugs, as determined by #CRISPR…
RT @EricTopol: 97% of #cancer drugs tested fail. Why? When @carlzimmer is on-target about off-target cancer drugs, as determined by #CRISPR…
Off-target drug toxicity. What we don't know can hurt or help us, or both #cancer @ScienceTM https://t.co/xUohjtbTbg
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
RT @EricTopol: 97% of #cancer drugs tested fail. Why? When @carlzimmer is on-target about off-target cancer drugs, as determined by #CRISPR…
RT @ChrisPickett5: This is a fantastic story https://t.co/fxrnHUUIoI
RT @EricTopol: 97% of #cancer drugs tested fail. Why? When @carlzimmer is on-target about off-target cancer drugs, as determined by #CRISPR…
Oh God. Please don't use RNAi ever again. Great thread.
RT @EricTopol: 97% of #cancer drugs tested fail. Why? When @carlzimmer is on-target about off-target cancer drugs, as determined by #CRISPR…
Off-target toxicity is a common mechanism of action of #cancer drugs undergoing clinical trials: https://t.co/n1NdO2EYi9
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
97% of #cancer drugs tested fail. Why? When @carlzimmer is on-target about off-target cancer drugs, as determined by #CRISPR @CSHL's @JSheltzer w/ a great team including undergrads, in @ScienceTM today https://t.co/IT6QHwJcqZ @NYTScience https://t.co/vUji
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
Fascinating work to experimentally show how little we know about drug targets. Congrats @JSheltzer and lab!
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
Very nice work!
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
This is a fantastic story
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
RT @boehninglab: Fantastic paper explainer thread https://t.co/npkXW4JLWo
https://t.co/5FNEtOgq41 @CSHL @ScienceTM @NewsfromScience
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
Congrats @JSheltzer and team! These data looked amazing during your talk at the @_Hubrecht. Time for me to dig in a bit deeper!
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
Fantastic paper explainer thread
RT @JSheltzer: Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in c…
This study is wild and suggests one reason why lab results don’t translate into clinical results.
Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in clinical trials. Also, we accidentally found the first-ever inhibitor of the cyclin-dependent kinase CDK11. https://t.co/Rthvr67cyk
[Research Articles] Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials https://t.co/85YNy5uKWh